CClinicalTrials.gg
CompletedNCT05786651Updated Oct 22, 2024Results posted

Task Switching Behavior Between Target Templates During Visual Search in Healthy Adults

An interventional study of Experimental: Within-Subjects Attentional Information in Healthy, sponsored by Lehigh University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-22.

Sponsored by Lehigh University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 years 4 months after the study started (first participant enrolled Oct 2018, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

In this line of research, the researchers having participants engage in task switching between tasks which require a positive (target) template, negative (distractor) template, or neutral (non-informative) template to the cognitive control factors associated with each template type during visual search. This is a basic science study.

Read the detailed description

The researchers will have participants engage in task switching between tasks which require a positive (target) template, negative (distractor) template, or neutral (non-informative) template to the cognitive control factors associated with each template type during visual search. Looking for impacts of task switching helps to identify the components of the cognitive control system that overlap between different types of attentional templates. This is a basic science study.

02

Conditions studied

  • Healthy

Keywords

  • attention
  • visual search
03

In context

Lead sponsor

Lehigh University is the lead sponsor of 16 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • normal or corrected to normal visual acuity, normal color vision

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Within-Subjects Attentional Information

    Within-Subjects, all participants receive all interventions

    Behavioral: Experimental: Within-Subjects Attentional Information

Interventions

  • BehavioralExperimental: Within-Subjects Attentional Information

    Visual Search Information Type (target or distractor information) Participants will have information about targets, distractors, or neither in different trials of the intervention.

06

What researchers measure

Primary outcomes

  1. Button Press Reaction Time

    Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see

    Time frame: One day (during testing)

  2. Button Press Accuracy

    Accuracy of responses to target item (% correct)- the researchers will measure whether the participants presses the correct button which corresponds to the target shape presented on the computer screen or the incorrect button

    Time frame: One day (during testing)

07

Results

Posted Oct 22, 2024

Participant flow

Lehigh University, normal or corrected to normal visual acuity and normal color vision

Participant flow — Overall Study
MilestoneWithin-Subjects Attentional Information
Started27
Completed26
Not completed1
Withdrew: Fire alarm during testing session, incomplete testing1

Outcome measures

PrimaryButton Press Reaction Time

Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see

Time frame:
One day (during testing)
Reported as:
Mean · Seconds
Button Press Reaction Time
SecondsWithin-Subjects Attentional Information
Positive cue: repeat cue meaning, repeat cue color1.68 ± .03
Positive cue: repeat cue meaning, change cue color1.69 ± .03
Positive cue: Change Meaning, repeat color1.76 ± .04
Positive cue: cue meaning change, cue color change1.77 ± .04
Negative cue: repeat cue meaning, repeat cue color1.93 ± .03
Negative cue: repeat cue meaning, change cue color1.97 ± .03
Negative cue: Change Meaning, repeat color1.78 ± .03
Negative cue: cue meaning change, cue color change1.88 ± .03
Statistical analysis
  • Within-Subjects Attentional Information · ANOVA · p = <.05
PrimaryButton Press Accuracy

Accuracy of responses to target item (% correct)- the researchers will measure whether the participants presses the correct button which corresponds to the target shape presented on the computer screen or the incorrect button

Time frame:
One day (during testing)
Reported as:
Mean · proportion correct
Button Press Accuracy
proportion correctWithin-Subjects Attentional Information
Positive cue: repeat cue meaning, repeat cue color.912 ± .008
Positive cue: repeat cue meaning, change cue color.926 ± .017
Positive cue: Change Meaning, repeat color.875 ± .014
Positive cue: cue meaning change, cue color change.852 ± .014
Negative cue: repeat cue meaning, repeat cue color.843 ± .017
Negative cue: repeat cue meaning, change cue color.819 ± .022
Negative cue: Change Meaning, repeat color.873 ± .016
Negative cue: cue meaning change, cue color change.835 ± .016
Statistical analysis
  • Within-Subjects Attentional Information · ANOVA · p = <.05

Adverse events

Collected over Day of testing. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Within-Subjects Attentional Information0/27 (0%)0/27 (0%)0/27 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Within-Subjects Attentional Information
<=18 years0
Between 18 and 65 years27
>=65 years0
Age, Continuous
Age, Continuous(years)Within-Subjects Attentional Information
Mean19.07 ± 1.11
Sex: Female, Male
Sex: Female, Male(Participants)Within-Subjects Attentional Information
Female15
Male12
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Within-Subjects Attentional Information
Region of Enrollment
Region of Enrollment(participants)Within-Subjects Attentional Information
United States27
08

Study locations

1 site
  • Lehigh University
    Bethlehem, Pennsylvania 18015, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 10, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The researchers plan to share anonymized subject data on Open Science Framework.

Supporting information: Study protocol, Sap

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05786651
Lead sponsor
Lehigh University
Responsible party
Sponsor
First posted
Mar 27, 2023
Start date
Oct 17, 2018
Primary completion
Nov 9, 2018
Completion
Nov 9, 2018
Results posted
Oct 22, 2024
Last update
Oct 22, 2024

Study contacts

Nancy Carlisle
principal investigator · Lehigh University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion